Literature DB >> 8320510

A randomized study of the surgical management of children with persistent otitis media with effusion associated with a hearing impairment.

J H Dempster1, G G Browning, S G Gatehouse.   

Abstract

The object of this study was to compare the effect on the hearing of the insertion of a grommet, with or without adenoidectomy, against a non-surgically managed control ear in children with persistent hearing impairment due to otitis media with effusion. Seventy-eight children (44 boys, 34 girls, mean age 5.8 years) with documented bilateral otitis media with effusion associated with a bilateral hearing impairment (pure tone average air conduction thresholds over 0.5, 1 and 2 kHz of > or = 25 dB HL) over a three month period were admitted to a randomized, controlled trial. Each child was randomized to have or not to have an adenoidectomy. The ears in each child were then randomly allocated to have a grommet (tympanostomy tube) inserted. The children's hearing status was reviewed six and 12 months post-operatively. During follow-up, should a child redevelop a persistent bilateral hearing impairment (as defined above) for three months they were managed with a hearing aid. Thus no child had repeat insertion of a grommet. Surgery of each type had an effect on the hearing and the presence of otitis media with effusion at six months post-operatively but not at 12 months when it was no different from natural resolution. If resolution of the otitis media with effusion is the outcome measure, then adenoidectomy alone is significantly better than no surgery but only in boys rather than in girls. Even in boys it only resolves about 60 per cent of effusions. However, when combined with a grommet (one insertion) adenoidectomy gives no greater resolution (89 per cent compared with 86 per cent).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8320510     DOI: 10.1017/s0022215100122844

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

1.  Otitis media with effusion in infants: is screening and treatment with ventilation tubes necessary?

Authors:  M M Rovers; K Ingels; G J van der Wilt; G A Zielhuis; P van den Broek
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

Review 2.  Adenoidectomy for recurrent or chronic nasal symptoms in children.

Authors:  Maaike Ta van den Aardweg; Anne Gm Schilder; Ellen Herkert; Chantal Wb Boonacker; Maroeska M Rovers
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 3.  Grommets in otitis media with effusion: an individual patient data meta-analysis.

Authors:  M M Rovers; N Black; G G Browning; R Maw; G A Zielhuis; M P Haggard
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

4.  Grommets and patient satisfaction: an audit.

Authors:  W P Hellier; R J Corbridge; G Watters; A P Freeland
Journal:  Ann R Coll Surg Engl       Date:  1997-11       Impact factor: 1.891

5.  The Importance of Integration of Stakeholder Views in Core Outcome Set Development: Otitis Media with Effusion in Children with Cleft Palate.

Authors:  Nicola L Harman; Iain A Bruce; Jamie J Kirkham; Stephanie Tierney; Peter Callery; Kevin O'Brien; Alex M D Bennett; Raouf Chorbachi; Per N Hall; Anne Harding-Bell; Victoria H Parfect; Nichola Rumsey; Debbie Sell; Ravi Sharma; Paula R Williamson
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

6.  The protective effect of adenoidectomy on pediatric tympanostomy tube re-insertions: a population-based birth cohort study.

Authors:  Mao-Che Wang; Ying-Piao Wang; Chia-Huei Chu; Tzong-Yang Tu; An-Suey Shiao; Pesus Chou
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

7.  The cost-effectiveness analysis of drug therapy versus surgery for symptomatic adenoid hypertrophy by a Markov model.

Authors:  Han Xiao; Jinqiang Huang; Weifeng Liu; Zihao Dai; Sui Peng; Zhenwei Peng; Ruiming Liang; Renqiang Ma; Yihui Wen; Jian Li; Weiping Wen
Journal:  Qual Life Res       Date:  2019-11-28       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.